UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Lifted by Rothschild Capital Partners LLC

Rothschild Capital Partners LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 17,266 shares of the healthcare conglomerate's stock after purchasing an additional 1,160 shares during the period. UnitedHealth Group makes up about 2.1% of Rothschild Capital Partners LLC's holdings, making the stock its 17th largest position. Rothschild Capital Partners LLC's holdings in UnitedHealth Group were worth $8,734,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently made changes to their positions in UNH. Norges Bank acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $6,375,744,000. Raymond James Financial Inc. acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $1,914,740,000. Amundi lifted its stake in UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after buying an additional 2,991,470 shares in the last quarter. Proficio Capital Partners LLC increased its position in UnitedHealth Group by 76,830.4% during the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock worth $955,388,000 after buying an additional 1,886,186 shares in the last quarter. Finally, Capital International Investors lifted its position in shares of UnitedHealth Group by 6.2% in the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after acquiring an additional 906,365 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on UNH. Truist Financial reduced their target price on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a report on Monday, April 21st. Cantor Fitzgerald restated an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. KeyCorp reduced their price target on UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Raymond James reiterated a "strong-buy" rating and issued a $540.00 target price (down from $635.00) on shares of UnitedHealth Group in a research note on Monday, April 21st. Finally, Erste Group Bank raised shares of UnitedHealth Group to a "strong-buy" rating in a research note on Wednesday, April 16th. Three investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of "Buy" and a consensus target price of $603.05.

UnitedHealth Group Stock Down 1.4 %

NYSE UNH traded down $6.05 on Friday, reaching $418.20. The company had a trading volume of 9,255,934 shares, compared to its average volume of 4,482,211. The firm has a 50-day moving average of $503.28 and a 200-day moving average of $534.62. UnitedHealth Group Incorporated has a 1 year low of $412.02 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $380.66 billion, a PE ratio of 26.98, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the business earned $6.91 earnings per share. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 2.01%. UnitedHealth Group's dividend payout ratio is presently 35.18%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.